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1. Introduction 
The synthesis of the majority of cholesterol esters 
in human plasma is catalyzed by lecithin cholesterol 
acyl transferase (LCAT) [ 1] and while the reaction 
takes place on the HDL particles, the cholesterol 
esters are transferred to other plasma lipoproteins by 
a protein carrier [Z]. On the basis of measurement of 
the LCAT reaction in vivo and in vitro [3] it appears 
that the production of cholesterol esters exceeds con- 
siderably the amount cleared from the circulation in 
the form of LDL and HDL particles [4]. Thus plasma 
cholesterol esters need to be removed by some addi- 
tional pathways. Since cholesterol esters are hydrolyzed 
quite rapidly following uptake by the liver [5] and by 
cultured cells [6,7] a cholesterol ester analogue, which 
is not rapidly degraded might prove useful in the elu- 
cidation of the role of various tissues in the uptake of 
lipoprotein cholesterol esters. [ 14C] Sucrose covalently 
bound to low density lipoproteins (LDL) was used in 
[8] as a non-degradable marker to follow the protein 
portion of the LDL particle into the lysosome. To 
follow the fate of the cholesterol ester moiety we 
have synthesized cholesterol alkyl ethers [9] and 
incorporated them into serum lipoproteins. This 
report deals with the determination of the non-de- 
gradability of these cholesterol ethers and their poten- 
tial suitability to serve as analogs for lipoprotein cho- 
lesterol esters. 
2. Materials and methods 
Human LDL and high-density lipoprotein (HDL) 
were isolated according to [lo], rat HDL was isolated 
at d = 1.085--l 21 g/ml. The labeled cholesteryl alkyl 
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ethers and cholesteryl linoleate were introduced into 
partially delipidated LDL using unlabeled cholesteryl 
linoleate as carrier [6]. HDL(6 mg protein/tube) were 
delipidated [6] and relipidation was carried out with 
6 mg cholesteryl linoleate containing trace amounts 
of either [“H]cholesteryl alkyl ethers or [3H]cho- 
lesteryl linoleate. 
Human skin fibroblasts were cultured as in [7]. The 
labeled lipoproteins were added to culture medium 
containing d > 1.25 fraction of human serum, 2.5 mg 
protein/ml. After 2 --4 days incubation, the cell layer 
was washed with 0.2% albumin in phosphate-buffered 
saline [7], the cells were released with trypsin [ 1 l] and 
the cell suspension washed by repeated centrifugation 
and resuspension in excess buffered saline [ 111. The 
labeled lipids were extracted from the pellet and tryp- 
sinate according to [ 121 and were analyzed by thin- 
layer chromatography (3% ethyl ether in light petro- 
leum, b.p. 30-60°C) using cholesterol linoleate and 
free cholesterol as reference standards. The relipidated 
rat HDL was injected into rats 180~-200 g body wt. 
which were killed by exsanguination under ether 
anesthesia 2-48 h thereafter. The radioactivity in 
organs was determmed in the chloroform phase after 
extraction of lipids according to [12], with a /3 liquid 
scintillation spectrometer, Packard, Model 2650. 
[3H]Cholesteryl linoleate was prepared as in [7] and 
>98% was recovered in esterified form. Synthesis of 
cholesteryl alkyl ethers was carried out by a modifica- 
tion [9] of the method in [13]. [7-~~H]Cholesterol 
was reacted with p-tosyl-chloride in dry pyridine at 
38°C for 20 h. The cholesterol tosylate extracted with 
hexane was heated at 110°C in the presence of an 
excess of fatty acid alcohol. Following extraction 
with hexane in the presence of excess NaHCO, the 
cholesterol alkyl ether was eluted from a silicic acid 
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Fig.1. Thin-layer chromatograph of labeled cholesteryl alkyl 
ethers. 
column in 15% benzene in hexane [9]. The R k.. of 
the cholesteryl alkyl ethers was similar to that of 
cholesteryl linoleate (fig.1). More than 98Y0 of the 
3H label was recovered as cholesteryl ether. Protein 
was determined as in [14]. [7-c+3H]Cholesterol was 
obtained from The Radiochemical Centre, Amersham 
and the fatty acid alcohols from Nu Chek, Elysian, MN. 
3. Results 
Cultured fibroblasts were incubated for 4 days with 
LDL labeled with [3H]cholesteryl oleyl ether and 
-10% of the added label were recovered in the cells 
after removal of surface-bound radioactivity by tryp- 
sinization (table 1). About 92-94% of the cellular 
[3H] lipid was recovered as unhydrolyzed cholesteryl 
ether. In cells exposed for 4 days to LDL-labeled with 
[3H]cholesteryl linoleate 98% of the labeled cellular 
lipid was found as free cholesterol. LDL labeled with 
[3H]cholesteryl cetyl or linoleyl ether was also taken 
up and the intracellular labeled lipid was recovered in 
unhydrolyzed form (94-96%). To verify the uptake 
of ‘reconstituted’ LDL by the cultured cells, the lipo- 
protein was delipidated as above and relipidated with 
non-labeled cholesterol linoleate and cholesteryl oleyl 
ether, and iodinated with “‘1 [l 11. The uptake and 
degradation [ 1 l] of the protein moiety of the ‘recon- 
stituted’ and native LDL were compared after 6 h 
incubation with human skin fibroblasts. The uptake 
and degradation of native “‘1 LDL were 10.9 f 0.3 
and 12.0 * 0.4 ng LDL protein/dish, while the uptake 
and degradation of the ‘reconstituted’ LDL ranged 
between 32-40 and 29-45 yg LDL protein/dish. 
Next the labeled compounds were injected i.v. into 
rats in the form of relipidated rat HDL. 2 h after injec- 
tion of HDL labeled with [3H]cholesteryl oleyl ether 
86% of the injected label was recovered in plasma and 
liver (table 2) and 95% of the labeled lipid was in 
unhydrolyzed form. When rats had been injected with 
Table 1 





[3H] Lipid in 
Trypsin Cells 
(dpm) 







2 930 6520 94 
4 1280 10 200 92 
4 600 3700 2 
Conditions: LDL relipidated with [3H]cholesteryl oleyl ether or with [‘Hlcholesteryl 
linoleate, 60 fig protein/ml and 5 X lo4 dpm/ml were added to 2 ml culture medium 
containing d > 1.25 fraction of human serum, 2.5 mg protein/ml. At the end of 
incubation, the cell layer was washed with 0.2% albumin in buffered saline and the 
cells were released by trypsinization. Values are means of duplicate dishes 
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Table 2 
Retention of [ ‘Hlcholesteryl oleyl ether in rat liver in vivo 
Labeled lipid Time after Liver Plasma 
in HDL injection (h) ~ 
% injected % hydro- % injected % hydro- 
dose lyzed dose lyzed 
Cholesteryl 2 50.3 4.8 35.7 5.3 
oleyl ether 48 65.7 6.1 7.8 79.0 
Cholesterol 2 32.6 96.6 23.5 91.0 
linoleate 48 7.0 _ 5.3 _ 
Rats were injected with 0.7-1.0 mg relipidated HDL protein which contained 
2 X 1 O5 dpm of either [‘HI cholesteryl oleyl ether or [ 3 H] cholesteryl linoleate. 
Values are means of duplicate determinations using 3 rats for each time 
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HDL labeled with [3H]cholesteryl linoleate >90% of 
the labeled lipid was found in free cholesterol. 48 h 
after injection of [3H] cholesteryl oleyl ether, the 
label in the liver increased to 65% injected dose of 
which 94Y0 were in non-hydrolyzed form. 
4. Discussion 
This study contains the first description of the 
metabolic fate of unsaturated cholesteryl alkyl ethers 
complexed to plasma lipoproteins. Since in the experi- 
ments with cultured human skin fibroblasts the cellular 
label had been determined after trypsinization it pro- 
vides evidence that these modified lipoproteins had 
been taken up by the cells. However, while the labeled 
cholesteryl ester of the reconstituted LDL had under- 
gone complete hydrolysis, the labeled cholesteryl 
ether remained almost intact. The reconstituted LDL 
was internalized and its protein moiety (‘*‘I-labeled) 
was degraded more avidly than the native LDL, 
probably owing to a change in particle size and shape 
as seen in negatively stained preparations. This different 
behavior proved beneficial for the purpose of the 
experiments here, the aim of which was to study the 
intracellular degradability of the cholesteryl alkyl 
ethers. The reconstituted HDL injected in vivo was 
also cleared more rapidly from the circulation than 
the native ‘*’ I-labeled HDL [ 151 and was probably 
removed in part by the scavenger pathway. This per- 
mitted to determine whether the cholesteryl ether will 
be stable also when ingested by tissue macrophages. 
Even after 48 h, when -66% of the injected dose was 
recovered in the liver, 94% of the labeled cholesteryl 
oleyl ether had not been hydrolyzed. This finding has 
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to be contrasted with the fate of cholesterol ester 
which had been complexed with HDL, and following 
injection into rats had been hydrolyzed in <2 h. 
Studies are in progress to introduce the labeled 
cholesterol ethers into plasma lipoproteins by a more 
physiological procedure, and preliminary findings indi- 
cate that indeed these compounds may serve as reliable 
markers to trace the extravascular fate of the cho- 
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